Zinc Responsive Dermatosis in Dogs: Arctic Breed Guide

By Emiel Maddens  ·  Reviewed in consultation with licensed veterinary professionals  ·  Updated June 2026  ·  10 min read

Photo by Karsten Winegeart on Unsplash

Zinc is an essential trace mineral that plays critical roles in hundreds of enzymatic processes throughout the body, including those governing skin cell division, immune function, wound healing, and protein synthesis. When zinc levels become insufficient, whether through inadequate dietary intake, impaired intestinal absorption, or genetic metabolic defects, the skin is often among the first organs to show clinical signs. Zinc responsive dermatosis is the term used to describe the spectrum of skin conditions in dogs that develop as a direct consequence of zinc deficiency and that improve or resolve with appropriate zinc supplementation. The condition has two recognized clinical syndromes, each with distinct breed predispositions, pathogenesis, and management requirements.

Syndrome I zinc responsive dermatosis occurs primarily in northern, Arctic-derived breeds, most notably Siberian Huskies and Alaskan Malamutes. These breeds carry a genetic defect that impairs the intestinal absorption of zinc, resulting in functional zinc deficiency despite consuming diets with adequate zinc content. The condition typically manifests in young adult dogs as symmetrical crusting, scaling, and alopecia around the eyes, mouth, ears, and pressure points. Because the underlying absorption defect is genetic and permanent, affected dogs require lifelong zinc supplementation to maintain adequate zinc status and prevent recurrence of skin lesions.

Syndrome II zinc responsive dermatosis affects rapidly growing puppies of any breed and results from absolute dietary zinc deficiency rather than an absorption defect. This form is most commonly associated with generic or poorly formulated commercial diets, home-prepared diets lacking adequate supplementation, or diets high in phytates (plant-based compounds found in grains and legumes) and calcium that bind zinc in the intestinal lumen and prevent its absorption. Unlike Syndrome I, Syndrome II is typically correctable through dietary modification and short-term zinc supplementation, with most affected puppies making a full recovery once adequate zinc nutrition is established.

The Role of Zinc in Skin Health

Zinc in Cellular Function

Zinc serves as a cofactor for over 300 enzymes and is a structural component of more than 2,000 transcription factors in the body, making it one of the most broadly essential trace minerals for normal physiological function. In the skin specifically, zinc is required for the normal proliferation and differentiation of keratinocytes, the cells that form the protective outer layer of the epidermis. Zinc-dependent enzymes, including alkaline phosphatase, carbonic anhydrase, and DNA and RNA polymerases, are essential for the rapid cell division that drives skin renewal. When zinc levels become insufficient, keratinocyte proliferation slows, differentiation becomes abnormal, and the resulting defective skin barrier is unable to maintain its protective function.

Zinc and Immune Function

Beyond its role in skin cell biology, zinc is critical for normal immune function, which has direct implications for skin health. Zinc deficiency impairs both innate and adaptive immune responses, reducing the ability of neutrophils and macrophages to eliminate pathogens, decreasing natural killer cell activity, and impeding T-lymphocyte maturation and function. This immune compromise explains why dogs with zinc responsive dermatosis are particularly susceptible to secondary bacterial and yeast skin infections that compound the primary zinc deficiency lesions. The immune-supportive effects of zinc supplementation contribute to the improvement in skin health observed when adequate zinc status is restored.

Sources and Metabolism of Zinc

Dietary zinc is absorbed primarily in the small intestine through both active transport (via specialized zinc transporter proteins) and passive diffusion. Zinc bioavailability, the proportion of dietary zinc that is actually absorbed and utilized, varies considerably depending on the dietary source and the presence of other dietary components that enhance or inhibit absorption. Animal-based zinc sources (meat, organ meats, fish) generally have higher bioavailability than plant-based sources. Phytates, found in cereal grains, legumes, and soy products, bind zinc in the intestinal lumen and form insoluble complexes that are excreted rather than absorbed. Excessive dietary calcium also inhibits zinc absorption by competing for shared transport mechanisms.

Syndrome I: Arctic Breed Zinc Malabsorption

Genetic Basis and Affected Breeds

Syndrome I zinc responsive dermatosis is an inherited condition that primarily affects Siberian Huskies and Alaskan Malamutes, although cases have been reported in Samoyeds, Bull Terriers, and other breeds. The genetic defect involves the intestinal zinc transporter proteins responsible for active zinc absorption in the small intestine. Dogs with this defect absorb significantly less dietary zinc than normal dogs, even when fed diets with adequate or above-adequate zinc content. The precise genetic mutation has not been fully characterized, but the strong breed predisposition and familial occurrence pattern are consistent with an autosomal recessive or incompletely penetrant mode of inheritance.

Age of Onset and Clinical Features

Syndrome I typically manifests in young adult dogs, usually between 1 and 3 years of age, though onset can occur at any age. The classic clinical presentation is bilateral, symmetrical crusting and scaling around the eyes (periocular), mouth (perioral), ears (particularly the ear pinnae and ear canal openings), and chin. The crusts are typically thick, adherent, and gray to yellowish-white in color, and they may crack and fissure, creating painful fissures in the skin. Additional lesion sites include the elbows, hocks, foot pads, and scrotum or vulva. The foot pads may show excessive keratinization with thickening, cracking, and fissuring that can cause lameness.

Secondary Complications

The compromised skin barrier and impaired local immunity associated with zinc deficiency predispose affected dogs to secondary infections that exacerbate the clinical picture. Staphylococcal bacterial infection produces pustules, papules, and crusting superimposed on the zinc deficiency lesions. Malassezia yeast overgrowth creates a greasy surface film, musty odor, and increased pruritus. These secondary infections can make the condition appear more severe than the zinc deficiency alone would produce and may initially lead to misdiagnosis as primary bacterial or yeast dermatitis. Treatment of secondary infections alongside zinc supplementation is necessary for optimal clinical improvement.

Arctic breeds require special attention to zinc nutrition for maintaining healthy skin.

Photo by Anya Prygunova on Unsplash

Syndrome II: Dietary Zinc Deficiency in Puppies

Causes of Dietary Deficiency

Syndrome II zinc responsive dermatosis results from absolute dietary zinc deficiency that may arise from several nutritional scenarios. Puppies fed generic, economy-brand commercial diets that contain insufficient zinc or zinc in poorly bioavailable forms are at highest risk. Home-prepared diets that have not been properly formulated with a veterinary nutritionist's guidance may lack adequate zinc supplementation. Diets with excessive calcium, either from over-supplementation by well-intentioned owners or from high calcium ingredient sources, inhibit zinc absorption. High-phytate diets, common in grain-heavy or plant-based formulations, bind dietary zinc and reduce its bioavailability. Rapidly growing large breed puppies are particularly vulnerable because their zinc requirements are elevated during periods of rapid skeletal and soft tissue growth.

Clinical Presentation in Puppies

The clinical signs of Syndrome II are similar to Syndrome I but tend to be more generalized and may include a greater degree of secondary infection. Affected puppies develop crusting, scaling, and hair loss that may involve the face, ears, pressure points, and extremities. Foot pad hyperkeratosis with cracking is common. The coat may appear dull and rough, and growth rate may be below expected standards for the breed. Puppies may show decreased appetite, lethargy, and increased susceptibility to infections beyond the skin, reflecting the systemic effects of zinc deficiency on immune function. In severe cases, lymph node enlargement and delayed wound healing may be evident.

Prognosis with Dietary Correction

The prognosis for Syndrome II is generally excellent because the underlying cause is correctable. Switching to a high-quality, complete and balanced commercial diet formulated for growth, combined with short-term zinc supplementation, typically produces visible improvement within 2 to 4 weeks. The crusty lesions soften, flake away, and are replaced by normal skin over the following weeks. Hair regrowth in previously affected areas usually occurs within 4 to 8 weeks. Once adequate dietary zinc intake is established and maintained, recurrence is unlikely unless the diet is changed to another inadequate formulation.

Diagnosis of Zinc Responsive Dermatosis

Clinical Recognition and History

The diagnosis of zinc responsive dermatosis begins with recognition of the characteristic clinical pattern combined with breed and dietary history. The combination of periocular, perioral, and ear crusting in a young adult Siberian Husky or Alaskan Malamute is highly suggestive of Syndrome I. Generalized crusting and poor coat quality in a rapidly growing puppy fed a low-quality or inappropriately supplemented diet points toward Syndrome II. The veterinarian will obtain a detailed dietary history, including the specific brand and formulation of food, any supplements being administered, and the duration of the current feeding regimen.

Skin Biopsy and Histopathology

Skin biopsy provides the most reliable diagnostic confirmation of zinc responsive dermatosis. Histopathological examination reveals a characteristic pattern of marked diffuse and follicular parakeratosis, which is the retention of nuclei in the cells of the stratum corneum (the outermost skin layer). In normal skin, the stratum corneum consists of anucleated (nucleus-free) keratinocytes. The parakeratotic pattern seen in zinc deficiency reflects abnormal keratinocyte differentiation due to insufficient zinc-dependent enzymatic activity. Additional findings may include variable epidermal hyperplasia, superficial perivascular inflammation, and secondary folliculitis. While not pathognomonic (uniquely diagnostic), this histopathological pattern in the appropriate clinical context strongly supports the diagnosis.

Zinc Level Testing

Serum zinc levels can be measured as part of the diagnostic workup but must be interpreted with caution. Zinc levels fluctuate with recent dietary intake, time of day, and physiological stress, and single measurements may not accurately reflect true body zinc stores. Normal serum zinc concentrations in dogs range from approximately 0.7 to 2.0 micrograms per milliliter, with values below 0.7 suggesting deficiency. However, dogs with Syndrome I may have low-normal serum zinc levels despite functional tissue deficiency, as the circulating zinc pool may be maintained at the expense of tissue stores. A therapeutic trial of zinc supplementation with clinical response assessment is often the most practical and informative diagnostic approach.

Ruling Out Other Conditions

The differential diagnosis for the crusty, scaly lesions of zinc responsive dermatosis includes several other dermatological conditions. Demodicosis, dermatophytosis, pemphigus foliaceus, superficial necrolytic dermatitis (hepatocutaneous syndrome), and generic dog food dermatosis must all be considered. Skin scraping, fungal culture, biopsy, and appropriate blood tests help rule out these conditions. Superficial necrolytic dermatitis, in particular, can produce very similar crusting patterns around the face and foot pads but is associated with severe hepatic (liver) disease and carries a much graver prognosis, making differentiation critically important.

Zinc Supplementation Protocols

Forms of Zinc Supplementation

Several forms of zinc are available for supplementation, with varying bioavailability and tolerability. Zinc methionine and zinc gluconate are generally preferred for canine supplementation due to their higher bioavailability compared to zinc oxide or zinc sulfate. Zinc sulfate, while less expensive, can cause gastrointestinal upset including nausea, vomiting, and diarrhea, particularly when administered on an empty stomach. Zinc methionine is a chelated form where the zinc is bound to the amino acid methionine, which enhances absorption and reduces gastrointestinal side effects. The choice of zinc formulation should be guided by the individual dog's tolerance and response.

Dosing for Syndrome I

Syndrome I zinc responsive dermatosis requires lifelong supplementation because the underlying absorption defect is permanent. Typical starting doses range from 2 to 3 mg/kg of elemental zinc per day, administered orally in divided doses with meals. Some dogs require higher doses, particularly during the initial treatment phase when body stores need to be replenished. Clinical response is assessed at 4 to 6 week intervals, and the dose is adjusted based on the resolution of skin lesions and the occurrence of any side effects. Once clinical remission is achieved, the lowest effective maintenance dose is determined and continued indefinitely. Periodic dose adjustments may be needed during periods of physiological stress such as estrus, pregnancy, or concurrent illness.

Dosing for Syndrome II

Syndrome II treatment combines dietary correction with temporary zinc supplementation. The puppy's diet should be changed to a high-quality, complete and balanced commercial food from a reputable manufacturer. Zinc supplementation at 1 to 2 mg/kg of elemental zinc daily is typically administered for 2 to 4 weeks to accelerate recovery while the improved diet takes effect. Once clinical signs have fully resolved and the puppy is receiving adequate dietary zinc, supplementation can usually be discontinued. Follow-up monitoring at 4 to 8 weeks after discontinuing supplementation confirms that the dietary correction alone is sufficient to maintain adequate zinc status.

Monitoring and Adjustments

Regular monitoring during zinc supplementation ensures therapeutic efficacy while minimizing the risk of zinc toxicity. Clinical assessment of skin condition at 4 to 6 week intervals guides dose adjustments. Serum zinc levels can be checked periodically, though clinical response is generally a more reliable indicator of adequate supplementation than laboratory values alone. Signs of zinc toxicity, which is rare at therapeutic doses, include gastrointestinal upset, lethargy, and potentially hemolytic anemia at very high doses. Concurrent copper status should be considered, as excessive zinc supplementation can interfere with copper absorption and potentially cause secondary copper deficiency over time.

Topical Management and Supportive Care

Keratolytic Therapy

The thick, adherent crusts associated with zinc responsive dermatosis benefit from topical keratolytic therapy to soften and remove the accumulations. Warm water soaks or compresses applied to crusted areas for 10 to 15 minutes help soften the crusts before gentle removal. Keratolytic shampoos containing salicylic acid, sulfur, or benzoyl peroxide help dissolve the excessive keratin deposits when used 2 to 3 times weekly. After bathing, emollient rinses or moisturizing sprays help restore moisture to the dry, crusted skin and promote normal barrier function. Forceful removal of crusts should be avoided, as this can damage the underlying skin and create entry points for secondary infection.

Managing Secondary Infections

Secondary bacterial and yeast infections are common complications of zinc responsive dermatosis and should be treated concurrently with zinc supplementation. Topical antimicrobial products, including chlorhexidine-based sprays and miconazole-chlorhexidine shampoos, help control surface bacterial and yeast populations. Systemic antibiotics may be needed for deep or widespread bacterial infection, guided by culture and sensitivity testing when possible. Antifungal therapy is indicated for confirmed Malassezia overgrowth. Treating secondary infections promptly improves patient comfort and allows clearer assessment of the response to zinc supplementation.

Omega-3 fatty acid supplementation provides additional skin barrier support and anti-inflammatory benefits that complement zinc therapy. Essential fatty acids help restore the epidermal lipid barrier, reduce inflammation-mediated scaling and crusting, and support overall skin health. A combined approach of zinc supplementation, appropriate diet, topical skin care, and essential fatty acid supplementation provides the most comprehensive management strategy for zinc responsive dermatosis.

Living with Zinc Responsive Dermatosis

Long-Term Management for Syndrome I Dogs

Owners of Arctic breed dogs diagnosed with Syndrome I zinc responsive dermatosis should understand that the condition requires lifelong management but can be effectively controlled with consistent supplementation. Developing a daily routine that incorporates zinc supplementation with meals ensures consistent dosing. Regular home inspection of the face, ears, and pressure points allows early detection of any recurrence that might indicate the need for dose adjustment. Most dogs with well-controlled Syndrome I zinc responsive dermatosis have an excellent quality of life and normal life expectancy, with the only ongoing requirement being daily oral zinc supplementation.

Dietary Considerations

For all dogs with zinc responsive dermatosis, dietary management plays an important supportive role. Feeding a high-quality commercial diet with good zinc bioavailability ensures the best baseline nutritional support. Avoiding excessive calcium supplementation is important, as excess calcium competes with zinc for intestinal absorption. Grain-heavy diets with high phytate content should be avoided or minimized, particularly for dogs with Syndrome I who already have impaired zinc absorption. Raw or homemade diets should be formulated with the guidance of a board-certified veterinary nutritionist to ensure all mineral requirements, including zinc, are met.

Breeders of Siberian Huskies and Alaskan Malamutes should be aware of the hereditary nature of Syndrome I and consider the implications for breeding decisions. While there is no commercially available genetic test for the condition, documenting affected individuals and their family lines helps breeders make informed decisions that may reduce the prevalence of the trait in future generations. Open communication about affected dogs within breed communities contributes to better overall breed health management.

Zinc Responsive Dermatosis in Dogs FAQ

Q: What breeds are most affected by zinc responsive dermatosis?

Syndrome I primarily affects Siberian Huskies and Alaskan Malamutes due to a genetic defect in zinc absorption. Cases have also been reported in Samoyeds, Bull Terriers, and occasionally other breeds. Syndrome II can affect any breed but is most common in rapidly growing large breed puppies fed low-quality or improperly formulated diets.

Q: Can zinc responsive dermatosis be cured?

Syndrome II (dietary deficiency) can be effectively cured by correcting the diet and providing short-term zinc supplementation. Once adequate dietary zinc is established, the condition does not recur. Syndrome I (genetic malabsorption) cannot be cured because the underlying absorption defect is permanent, but it can be effectively controlled with lifelong oral zinc supplementation. Most dogs with well-managed Syndrome I live normal, comfortable lives.

Q: How much zinc should I give my dog?

Zinc supplementation should always be prescribed by a veterinarian based on your dog's specific diagnosis, weight, and clinical response. Typical doses for Syndrome I range from 2 to 3 mg/kg of elemental zinc daily, while Syndrome II typically requires 1 to 2 mg/kg daily for a shorter duration. Over-supplementation can cause zinc toxicity, so veterinary guidance is essential for safe and effective dosing.

Q: What does zinc responsive dermatosis look like?

The condition produces thick, adherent crusts and scales that typically form around the eyes, mouth, ears, and chin. The crusts are often gray to yellowish-white and may crack and fissure. Hair loss surrounds the crusted areas. The foot pads may become thickened, cracked, and painful. In more severe cases, lesions can extend to the elbows, hocks, and genital areas. Secondary bacterial or yeast infection may add redness, pustules, and a musty odor.

Q: Can I prevent zinc deficiency by adding zinc to my dog's food?

Adding zinc supplements to a balanced commercial diet is generally unnecessary and can cause imbalances if done without veterinary guidance. High-quality commercial diets formulated to meet AAFCO standards contain adequate zinc for most dogs. If your dog is an Arctic breed with Syndrome I, supplementation should be guided by a veterinarian. For all other dogs, feeding a reputable, balanced diet and avoiding excessive calcium or phytate-rich foods supports normal zinc nutrition.

Sources

White, S.D., Bourdeau, P., Rosychuk, R.A.W., et al. (2001). Zinc-responsive dermatosis in dogs: 41 cases and literature review. Veterinary Dermatology, 12(2), 101-109.

Colombini, S., Dunstan, R.W. (1997). Zinc-responsive dermatosis in northern-breed dogs: 17 cases (1990-1996). JAVMA, 211(4), 451-453.

Marsh, K.A., Ruedisueli, F.L., Coe, S.L., Watson, T.D.G. (2000). Effects of zinc and linoleic acid supplementation on the skin and coat quality of dogs receiving a complete and balanced diet. Veterinary Dermatology, 11(4), 277-284.

van den Broek, A.H.M., Thoday, K.L. (1986). Skin disease in dogs associated with zinc deficiency: a report of five cases. Journal of Small Animal Practice, 27(5), 313-323.

Gross, T.L., Ihrke, P.J., Walder, E.J., Affolter, V.K. (2005). Skin Diseases of the Dog and Cat, 2nd ed. Blackwell Publishing. Chapter on nutritional skin diseases.

National Research Council (2006). Nutrient Requirements of Dogs and Cats. National Academies Press. Sections on trace mineral requirements.

Related Reading

• Pyoderma in Dogs, Secondary bacterial infections that complicate zinc deficiency
• Yeast Dermatitis in Dogs, Malassezia overgrowth common with compromised skin barriers
• Pemphigus in Dogs, Autoimmune crusting condition in the differential diagnosis
• How Vets Diagnose Skin Problems, Diagnostic approaches including biopsy for nutritional skin disease
• Understanding Skin Biopsy Results, How histopathology identifies zinc-deficiency skin patterns

Emiel Maddens

Founder of Vetified. Develops topical antifungal and antimicrobial formulations for companion animals. Vetified products are listed on DailyMed and manufactured through FDA-registered facilities in the United States.